scispace - formally typeset
M

Marge C. Lenane

Researcher at National Institutes of Health

Publications -  8
Citations -  1163

Marge C. Lenane is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Clomipramine & Desipramine. The author has an hindex of 6, co-authored 8 publications receiving 1153 citations. Previous affiliations of Marge C. Lenane include University of Maryland, Baltimore.

Papers
More filters
Journal ArticleDOI

Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison

TL;DR: In this article, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia in a 6-week double-blind parallel comparison.
Journal ArticleDOI

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

TL;DR: A 10-week double-blind crossover trial of clomipramine hydrochloride (mean dose [+/- SD], 150 +/- 53 mg/d) and desipramines hydrochlorides (means dose = 153 +/- 55 mg/D) was conducted in this paper.
Journal Article

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents : a double-blind crossover comparison

TL;DR: The specificity of the antiobsessional effect of clomipramine and the need for maintenance treatment is documented, and age at onset, duration and severity of illness, type of symptom, and plasma drug concentrations did not predict clinical response.
Journal ArticleDOI

"Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia?

TL;DR: The findings support the distinction of the multidimensionally impaired cases as separate from those with other psychiatric disorders, and there is somewhat greater evidence to suggest that this disorder belongs in the schizophrenia spectrum.

An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations

TL;DR: Patients with childhood-onset obsessive-compulsive disorder (OCD) with symptom exacerbations following streptococcal infections benefit from treatment with plasma exchange, but Plasma exchange does not benefit children and adolescents with OCD who do not have strePTococcus-related exacerbations.